Page last updated: 2024-11-04

tegafur and Burkitt Lymphoma

tegafur has been researched along with Burkitt Lymphoma in 2 studies

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vrba, M1
Adámek, R1
Blasko, M1
Brezina, V1
Chrz, R1
Goetz, P1
Michalová, K1
Musilová, J1
Novotná, B1
Pogosianz, HE1
Raposa, T1
Siracký, J1
Sokova, OI2
Thust, R1
Ujházy, V1
Volgareva, GM2
Pogosiants, EE1

Other Studies

2 other studies available for tegafur and Burkitt Lymphoma

ArticleYear
Clastogenicity and sister chromatid exchange induction by ftorafur.
    Neoplasma, 1981, Volume: 28, Issue:4

    Topics: Animals; Burkitt Lymphoma; Cell Line; Chromosomes; Chromosomes, Human; Cricetinae; Crossing Over, Ge

1981
[Effect of ftorafur on the chromosomes of human normal and tumor cells in vitro].
    Genetika, 1979, Volume: 15, Issue:1

    Topics: Burkitt Lymphoma; Cells, Cultured; Chromosomes, Human; Dose-Response Relationship, Drug; Fluorouraci

1979